I cant see there there been to much downside.Asia was down due oz rollout fy 2020 so will be playing catch up,new markets opening and new product launches this year.Why do you think spill over will be only q1?Covid definitely no where near under control and the world screaming out for immune boosting products.Its theirs to lose if they cant gain market penertration from here they never will